Real Drugs Private Limited, a active private limited company, was established on 08 October 2004 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239DL2004PTC129775. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Naresh Kumar Goyal (Additional Director), Manoj Kumar Jha (Additional Director), Kapil Goyal (Director). Past directors included Vivek Goyal, Rakesh Prasad, Pawan Kumar. It holds ₹2.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 1201, 12Th Floor, D-Mall ,Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
U24239DL2004PTC129775
129775
08 October 2004
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Real Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naresh Kumar Goyal | Additional Director | 23 Sep 2024 | Current |
| Manoj Kumar Jha | Additional Director | 19 Sep 2024 | Current |
| Kapil Goyal | Director | 23 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Director | 28 Jan 2009 | Past |
| Pramod Abcsdd | Additional Director | 04 Feb 2024 | Past |
| Pramod Abcsdd | Director | 22 Jan 2008 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Real Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.35% decrease. The company also saw a slight improvement in profitability, with a 6.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 546.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Real Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2024 | Hdfc Bank Limited | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Real Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Real Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Real Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Real Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Naresh Kumar Goyal was appointed as a Additional Director was appointed as a Additional Director on 23 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Manoj Kumar Jha was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 25.00 M with Charge ID 100954970 was registered on 19 Jun 2024. was documented.
Progress on Real Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Kapil Goyal was appointed as a Director was appointed as a Director on 23 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The CIN of Real Drugs Private Limited is U24239DL2004PTC129775.
Real Drugs Private Limited is headquartered at Unit No. 1201, 12Th Floor, D-Mall ,Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
Real Drugs Private Limited was incorporated on 08 October 2004.
The current directors of Real Drugs Private Limited are
The primary industry of Real Drugs Private Limited is Trade.
Real Drugs Private Limited is unlisted.
The authorized capital of Real Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Real Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX